Martin H Voss

39PUBLICATIONS
141CO-AUTHORS
Tumour immunologyMicrobial geneticsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 29, 2026
Complete response to dual immune checkpoint blockade in a patient with Birt-Hogg-Dubé syndrome and epithelioid angiomyolipoma.

|Apr 08, 2026
From diversity to function: microbiome precision in RCC.

Antonio Ocejo, Ritesh R Kotecha, Martin H Voss

|Jan 02, 2026
Mechanistic insights make cancer cachexia a targetable syndrome.

Ed Reznik, Martin H Voss, A Ari Hakimi

|Jan 31, 2025
Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial.

Matthew Tucker, Yu-Wei Chen, Martin H Voss

|Jul 26, 2024
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.

Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack

|Oct 21, 2023
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.

Ritesh R Kotecha, Andrea Knezevic, Kanika Arora

Pageof 7

Frequent Collaborators

22 joint publications

Robert J Motzer

15 joint publications

Ritesh R Kotecha

9 joint publications

Ed Reznik

7 joint publications

Maria Isabel Carlo